Difference between revisions of "User:Tarsheensethi"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "thumb|Tarsheen Sethi MD, MSCI Dr. Tarsheen Sethi is an Instructor in Medicine in the division of Hematology-Oncology at Vanderbilt University Medica...")
 
 
Line 1: Line 1:
 
[[File:TarsheenSethi.jpg|thumb|Tarsheen Sethi MD, MSCI]]
 
[[File:TarsheenSethi.jpg|thumb|Tarsheen Sethi MD, MSCI]]
Dr. Tarsheen Sethi is an Instructor in Medicine in the division of Hematology-Oncology at Vanderbilt University Medical Center. Her clinical expertise is in lymphoid malignancies and histiocytic disorders. Her research focuses on early phase clinical trials and biomarker studies particularly those involving targeted agents and immunotherapy in lymphoma. In addition, she is interested in outcome and real world evidence studies in lymphoid malignancies.
+
Dr. Tarsheen Sethi is an Assistant Professor of Medicine in the division of Hematology at Yale University. Her clinical expertise is in lymphoid malignancies and histiocytic disorders. Her research focuses on early phase clinical trials and biomarker studies particularly those involving targeted agents and immunotherapy in lymphoma. In addition, she is interested in outcome and real world evidence studies in lymphoid malignancies.
 +
 
 +
She is the HemOnc.org Section Editor of [[:Category:Aggressive lymphomas|Aggressive Lymphomas]].

Latest revision as of 00:27, 29 August 2023

Tarsheen Sethi MD, MSCI

Dr. Tarsheen Sethi is an Assistant Professor of Medicine in the division of Hematology at Yale University. Her clinical expertise is in lymphoid malignancies and histiocytic disorders. Her research focuses on early phase clinical trials and biomarker studies particularly those involving targeted agents and immunotherapy in lymphoma. In addition, she is interested in outcome and real world evidence studies in lymphoid malignancies.

She is the HemOnc.org Section Editor of Aggressive Lymphomas.